AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
FDA Rejects a Softer Touch on AI Medical Devices, Preserving a Higher Regulatory Bar
The FDA has rejected a proposal to ease oversight of AI medical devices, reinforcing that software claiming clinical value will remain under serious scrutiny. The decision may frustrate some developers, but it also confirms that regulators are still prioritizing safety over speed.
FDA Draws a Harder Line on AI Software as Medtech Pushes Back
Two new takes on the FDA’s evolving AI posture underscore a central tension in digital health: regulators are trying to apply legacy device frameworks to software that updates continuously and learns over time. The result is a widening gap between how AI is built and how it is governed.
FDA Rejects Industry Push to Loosen Oversight of Some AI Devices
The FDA has reportedly turned down an industry proposal that would have eased regulation for certain AI-enabled medical devices, signaling the agency is not ready to treat software risk as inherently lower simply because it can be updated quickly. The decision reinforces a more cautious regulatory posture just as manufacturers are pressing for faster pathways for iterative AI products.
FDA’s lighter-touch digital health stance may speed innovation—but shift pressure to evidence and governance
A Healio Q&A suggests the FDA is loosening aspects of oversight for digital health innovation, reflecting a more adaptive posture toward software-driven care tools. That could accelerate product iteration, but it also increases the burden on developers and providers to prove safety, monitor performance, and govern real-world use.
FDA’s Oncology AI Program Signals a More Organized Path for Cancer Algorithms
The FDA’s Oncology Center of Excellence is putting sharper structure around how artificial intelligence will be evaluated in cancer care. That matters because oncology has become one of the fastest-moving and highest-risk settings for clinical AI, where diagnostic, treatment, and workflow tools can directly shape life-altering decisions.
Healthcare AI Regulation Enters a More Practical Phase
The healthcare AI policy debate is shifting from broad principles to implementation details around evidence, updates, risk management, and accountability. That transition matters because the next bottleneck for AI in care is no longer whether regulation is coming, but whether developers and providers can operate within it efficiently.
FDA’s New Cybersecurity Standard Move Shows AI Medical Devices Will Be Regulated as Connected Systems
The FDA has added AAMI cybersecurity guidance to its recognized consensus standards database, reinforcing cybersecurity as a core expectation for medical devices. For AI-enabled products, the move is a reminder that performance claims alone are no longer enough; secure lifecycle management is becoming part of market access.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.